MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Midazolam Hydrochloride Preservative Free, and what generic alternatives are available?
Midazolam Hydrochloride Preservative Free is a drug marketed by Fresenius Kabi Usa, Hospira, and Steriscience. and is included in three NDAs.
The generic ingredient in MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Midazolam Hydrochloride Preservative Free
A generic version of MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE was approved as midazolam hydrochloride by FRESENIUS KABI USA on June 20th, 2000.
Summary for MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Clinical Trials: | 14 |
Patent Applications: | 1,090 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE at DailyMed |
Recent Clinical Trials for MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fayoum University | Phase 1 |
Tanta University | Early Phase 1 |
Cairo University | Phase 4 |
See all MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE clinical trials
Pharmacology for MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
Drug Class | Benzodiazepine |